论文部分内容阅读
胰腺癌早期诊断困难,80%的患者就诊时已发生局部进展或远处转移。目前,手术切除仍是胰腺癌患者获得长期生存的唯一方法。近年来,胰腺癌综合治疗水平较前有所提高。针对临界可切除胰腺癌进行新辅助治疗,可以达到降期,甄别人群,筛选潜在获益人群进行手术的目的。合理选择有效化疗方案,恰当选择手术时机,能进一步提高胰腺癌的切除率,从而延长该类高危人群的生存期。
Early diagnosis of pancreatic cancer is difficult, 80% of patients have been treated when the local progress or distant metastasis. Currently, surgical resection is still the only way to obtain long-term survival of patients with pancreatic cancer. In recent years, the comprehensive treatment of pancreatic cancer has increased compared with the previous. Neo-adjuvant therapy for critical resectable pancreatic cancer can achieve the purpose of surrender, screening of the crowd and screening potential beneficiaries for surgery. Reasonable choice of effective chemotherapy, the appropriate choice of timing of surgery, can further improve the resection rate of pancreatic cancer, thereby extending the survival of such high-risk groups.